Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients.
Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter CB, Huntemann N, Mergenthaler P, Arat E, Öztürk M, Foell D, Schreiber S, Vielhaber S, Gassa A, Stetefeld H, Schroeter M, Berger B, Totzeck A, Hagenacker T, Meuth SG, Meisel A, Wiendl H, Ruck T. Nelke C, et al. Among authors: schroeter cb, schroeter m. J Neuroinflammation. 2022 Apr 12;19(1):89. doi: 10.1186/s12974-022-02448-4. J Neuroinflammation. 2022. PMID: 35413850 Free PMC article.
[Myasthenic Crisis].
Stetefeld HR, Schroeter M. Stetefeld HR, et al. Among authors: schroeter m. Fortschr Neurol Psychiatr. 2018 May;86(5):301-307. doi: 10.1055/a-0599-0811. Epub 2018 May 29. Fortschr Neurol Psychiatr. 2018. PMID: 29843179 Review. German.
Ocrelizumab initiation in patients with MS: A multicenter observational study.
Ellwardt E, Rolfes L, Klein J, Pape K, Ruck T, Wiendl H, Schroeter M, Zipp F, Meuth SG, Warnke C, Bittner S. Ellwardt E, et al. Among authors: schroeter m. Neurol Neuroimmunol Neuroinflamm. 2020 Apr 9;7(4):e719. doi: 10.1212/NXI.0000000000000719. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32273482 Free PMC article.
SOP myasthenic crisis.
Stetefeld H, Schroeter M. Stetefeld H, et al. Among authors: schroeter m. Neurol Res Pract. 2019 Jul 29;1:19. doi: 10.1186/s42466-019-0023-3. eCollection 2019. Neurol Res Pract. 2019. PMID: 33324885 Free PMC article.
A Sum Score to Define Therapy-Refractory Myasthenia Gravis: A German Consensus.
Schroeter M, Berger B, Blaes F, Hagenacker T, Jander S, Kaiser J, Kalischewski P, Lee DH, Ruck T, Schara U, Urban P, Meisel A. Schroeter M, et al. J Cent Nerv Syst Dis. 2021 Feb 1;13:1179573521989151. doi: 10.1177/1179573521989151. eCollection 2021. J Cent Nerv Syst Dis. 2021. PMID: 33597816 Free PMC article.
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.
Rolfes L, Pawlitzki M, Pfeuffer S, Nelke C, Lux A, Pul R, Kleinschnitz C, Kleinschnitz K, Rogall R, Pape K, Bittner S, Zipp F, Warnke C, Goereci Y, Schroeter M, Ingwersen J, Aktas O, Klotz L, Ruck T, Wiendl H, Meuth SG. Rolfes L, et al. Among authors: schroeter m. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 14;8(5):e1035. doi: 10.1212/NXI.0000000000001035. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34261812 Free PMC article.
Eculizumab versus rituximab in generalised myasthenia gravis.
Nelke C, Schroeter CB, Stascheit F, Pawlitzki M, Regner-Nelke L, Huntemann N, Arat E, Öztürk M, Melzer N, Mergenthaler P, Gassa A, Stetefeld H, Schroeter M, Berger B, Totzeck A, Hagenacker T, Schreiber S, Vielhaber S, Hartung HP, Meisel A, Wiendl H, Meuth SG, Ruck T. Nelke C, et al. Among authors: schroeter cb, schroeter m. J Neurol Neurosurg Psychiatry. 2022 May;93(5):548-554. doi: 10.1136/jnnp-2021-328665. Epub 2022 Mar 4. J Neurol Neurosurg Psychiatry. 2022. PMID: 35246490 Free PMC article.
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal.
Meisel A, Baggi F, Behin A, Evoli A, Kostera-Pruszczyk A, Mantegazza R, Morales RJ, Punga AR, Sacconi S, Schroeter M, Verschuuren J, Crathorne L, Holmes K, Leite MI. Meisel A, et al. Among authors: schroeter m. Eur J Neurol. 2023 Jan;30(1):266-282. doi: 10.1111/ene.15565. Epub 2022 Oct 7. Eur J Neurol. 2023. PMID: 36094738 Review.
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
Stascheit F, Grittner U, Hoffmann S, Mergenthaler P, Schroeter M, Ruck T, Pawlitzki M, Blaes F, Kaiser J, Schara U, Della-Marina A, Thieme A, Hagenacker T, Jacobi C, Berger B, Urban PP, Knop KC, Schalke B, Lee DH, Kalischewski P, Wiendl H, Meisel A. Stascheit F, et al. Among authors: schroeter m. J Neurol. 2023 Jan;270(1):1-12. doi: 10.1007/s00415-022-11389-0. Epub 2022 Sep 27. J Neurol. 2023. PMID: 36166068 Free PMC article.
Weaning and extubation failure in myasthenic crisis: a multicenter analysis.
Neumann B, Angstwurm K, Dohmen C, Mergenthaler P, Kohler S, Schönenberger S, Lee DH, Gerner ST, Huttner HB, Thieme A, Steinbrecher A, Dunkel J, Roth C, Schneider H, Reichmann H, Fuhrer H, Kleiter I, Schneider-Gold C, Alberty A, Zinke J, Schroeter M, Linker R, Meisel A, Bösel J, Stetefeld HR; Initiative of German NeuroIntensive Trial Engagement (IGNITE). Neumann B, et al. Among authors: schroeter m. J Neurol. 2024 Jan;271(1):564-574. doi: 10.1007/s00415-023-12016-2. Epub 2023 Nov 3. J Neurol. 2024. PMID: 37923937
473 results